Diabetes technology

Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes

Diabetes Technol TherPublished Retrospective cohort study

Authors' conclusion

For rebound and extended metrics, the most important metric was the number of events/week. RHyper and RHypo had a stronger correlation with CV and hypoglycemia metrics (TBR) than the correlation between CV and TBR. Thus, rebound events have the potential to detect hypoglycemia events caused by glycemic variability.

Study context

Population
CGM users with ≥90 days of CGM data, randomly selected from Dexcom Clarity database
Participants
30,000 users
Outcome
Correlations between new CGM metrics (RHyper, RHypo, EHyper, EHypo) and standard metrics

Main finding

As reported in the abstract

Coefficient of variation (CV) correlation with rebound hyperglycemia (RHyper) (70-180 mg/dL) events/week

r = 0.67

CV correlation with rebound hypoglycemia (RHypo) (180 to 70 mg/dL) events/week

r = 0.64

Time in range correlation with extended hyperglycemia (EHyper) events/week (strongest among new metrics)

r = −0.88

Correlation between RHyper and RHypo events

r = 0.92

Observational data: associations, not effects.

Further findings

Standard CGM metrics

Mean time in 70-180 mg/dL
61.8 ± 20.7%
Mean glucose
173 ± 37.1 mg/dL
CV
32.1 ± 7.2%

Original publication

Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes. Diabetes Technol Ther. Published 11 September 2025. doi:10.1177/15209156251377797

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.